Strategic partnerships
For 40 years, Ypsomed has built a network of trusted strategic partners who, just like Ypsomed, serve as key suppliers to our pharmaceutical customers. Over the past 20 years, these relationships have evolved from cartridge-based peptide therapies for pens to include syringe-based autoinjector therapies that meet the needs of both pharmaceutical companies and patients for antibody-based treatments.
While Ypsomed strives to be best-in-class in the development and manufacturing of self-injection devices, we partner with these key suppliers to ensure that the drug–device combination product is delivered quickly, on time, and meets the needs of both pharmaceutical companies and patients.
By nurturing strategic partnerships, pharma customers profit from best-in-class systems which provide reduced costs and shorter timelines during the clinical, approval and commercial phases for each drug product.
Trusted partnerships for proven quality
Ypsomed’s platform products are optimized for efficient production by design, enabling our partners to deliver proven, reliable solutions. The partners listed on the following pages have continuously demonstrated excellence in quality, reliability, and expertise, offering our customers confidence and assurance at every stage.
Primary container compatibility specialist
The starting point for every injection drug-device combination product is the primary drug container, namely a cartridge or pre-filled syringe. These containers are typically glass, though some may be polymer-based, but only function as a container system in combination with the elastomeric components that seal the drug in the container, e.g. bilayer combiseal, needle shield or plunger.
Understanding the primary drug container system and its interfaces with the injection device is critical. Ypsomed collaborates and consults with customers during the entire project to ensure that the selected drug container is fully compatible with the Ypsomed platform product whether the device is a pen injector, autoinjector or patch injector.
Ypsomed collaborates with over 15 different glass and elastomer manufacturers worldwide and tests the container variant prior to and during every project. When a primary drug container needs to be developed for a new platform injector, Ypsomed collaborates with leading suppliers to define and develop new industry standards such as for YpsoMate 5.5mL and YpsoDose 10mL.
Fill and finish CMOs
Understanding the cartridge or pre-filled syringe dimensions is important, but understanding the filling process and the filled container as a system are critical to completing successfully the necessary ISO verification testing for each combination product.
Ypsomed collaborates with sterile filling equipment manufacturers to keep up-to-date with the latest filling process developments. Their equipment is located within pharma manufacturing and within the global network of contract development and manufacturing organisations or CMOs which are involved in more than 50% of all projects.
With over 150 active customers and over 70 products already on the market, Ypsomed is a proactive and fully integrated player in the global pharma and CMO manufacturing network.
Final assembly equipment and CMOs
Final assembly of the drug with the prefilled pen injector, autoinjector, or patch injector device is fundamental to the success of drug-device combination products. The development of easy-to-assemble platform products led Ypsomed to collaborate with a group of leading assembly equipment manufacturers.
These companies provide scalable assembly solutions for both clinical and commercial supply based on clearly specified ready-to-order equipment. This extends to process aspects such as functional release testing, labeling and final packaging.
If a pharma customer is considering final assembly, Ypsomed is at hand to make recommendations based on its established global network of fill/finish and final assembly CMOs that have installed capacity for Ypsomed platforms.
Ypsomed’s strategic partner network includes
all leading final assembly equipment suppliers
Strategic networking is part of our DNA
Drug-device development is complex and requires more than just an understanding of the device itself. At Ypsomed, we are passionate about working within and fully understanding all aspects of our ecosystem. Whether you are looking to establish contact within the global drug-device consulting network, you are looking to source trainer devices, or simply other specialized expertise, just reach out to us. We are always happy to support you.
